These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31523362)

  • 1. Antiretroviral drug-S for a possible HIV elimination.
    Agas A; Schuetz H; Mishra V; Szlachetka AM; Haorah J
    Int J Physiol Pathophysiol Pharmacol; 2019; 11(4):149-162. PubMed ID: 31523362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques.
    Mavigner M; Habib J; Deleage C; Rosen E; Mattingly C; Bricker K; Kashuba A; Amblard F; Schinazi RF; Lawson B; Vanderford TH; Jean S; Cohen J; McGary C; Paiardini M; Wood MP; Sodora DL; Silvestri G; Estes J; Chahroudi A
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy.
    Perez S; Johnson AM; Xiang SH; Li J; Foley BT; Doyle-Meyers L; Panganiban A; Kaur A; Veazey RS; Wu Y; Ling B
    J Neurovirol; 2018 Feb; 24(1):62-74. PubMed ID: 29181724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy.
    Balcom EF; Roda WC; Cohen EA; Li MY; Power C
    Curr Opin Virol; 2019 Oct; 38():54-62. PubMed ID: 31390580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.
    Reeves DB; Peterson CW; Kiem HP; Schiffer JT
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28404854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short Communication: Ultrasensitive Immunoassay for Assessing Residual Simian-Tropic HIV in Nonhuman Primate Models of AIDS.
    Swanstrom AE; Jacques A; Del Prete GQ; Bieniasz P; Hatziioannou T; Gorelick R; Lifson JD
    AIDS Res Hum Retroviruses; 2019 May; 35(5):473-476. PubMed ID: 30632394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Active HIV-1 Infection in CD34
    Latinovic OS; Neal LM; Tagaya Y; Heredia A; Medina-Moreno S; Zapata JC; Reitz M; Bryant J; Redfield RR
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):718-728. PubMed ID: 31099257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
    Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
    J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection.
    Long S; Fennessey CM; Newman L; Reid C; O'Brien SP; Li Y; Del Prete GQ; Lifson JD; Gorelick RJ; Keele BF
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment.
    Gupta S; Kesarla R; Omri A
    Expert Opin Drug Deliv; 2019 Mar; 16(3):287-300. PubMed ID: 30779602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Challenges of HIV-1 Infection: How HIV-1 Attacks and Resides in the Central Nervous System.
    Rojas-Celis V; Valiente-Echeverría F; Soto-Rifo R; Toro-Ascuy D
    Cells; 2019 Oct; 8(10):. PubMed ID: 31614895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious Virus Persists in CD4
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
    Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling brain lentiviral infections during antiretroviral therapy in AIDS.
    Roda WC; Li MY; Akinwumi MS; Asahchop EL; Gelman BB; Witwer KW; Power C
    J Neurovirol; 2017 Aug; 23(4):577-586. PubMed ID: 28512685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current developments and future prospects for HIV gene therapy using interfering RNA-based strategies.
    Lamothe B; Joshi S
    Front Biosci; 2000 May; 5():D527-55. PubMed ID: 10799355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction.
    Ostrowski M; Benko E; Yue FY; Kim CJ; Huibner S; Lee T; Singer J; Pankovich J; Laeyendecker O; Kaul R; Kandel G; Kovacs C
    Open Forum Infect Dis; 2015 Dec; 2(4):ofv138. PubMed ID: 26512359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.